Perseus Proteomics Inc.

Perseus Proteomics Inc. is a dynamic biopharmaceutical company focused on discovering and developing innovative antibody drugs. With a commitment to advancing therapeutic solutions, Perseus Proteomics is dedicated to running clinical programs to bring cutting-edge treatments to patients. Located in Meguro, Tokyo 153-0041, JP, Perseus Proteomics operates as a public company, driving advancements in pharmaceutical manufacturing since its establishment in 2001.

Perseus Proteomics is committed to developing high-quality antibody drugs. Perseus Proteomics strives to meet unmet medical needs. Through rigorous research and clinical trials, Perseus Proteomics ensures the efficacy and safety of its pharmaceutical products, contributing significantly to the healthcare industry.

With a dedicated team, Perseus Proteomics is poised for continued growth and success in the biopharmaceutical sector. The company’s Meguro, Tokyo headquarters serves as a hub for innovation and collaboration. We invite the management team at Perseus Proteomics to enhance this profile with a customized company showcase and exclusive product listings on our platform.